Graphene-based materials can be obtained using various reducing agents, many of which are dangerous and toxic chemicals, and the obtained graphene-based materials are prone to aggregation, limiting their practical applications.
Read More | Phys.org news tagged with:graphene
Bio & Medicine Nanomaterials
More Graphene news
STEK Automotive launches graphene-enhanced window films
Creating new opportunities from nanoscale materials
Cardea Bio partners with Scentian Bio to create a bio-electronic tongue/nose platform
Cardea Bio and the Georgia Tech Research Institute enter DARPA agreement to develop airborne SARS-CoV-2 sensors
Cardea Bio Adds $6.5 Million to its Series A fundraises
Physicists record “lifetime” of graphene qubits
Graphmatech uses its graphene technology to push forward copper additive manufacturing
Engineering the boundary between 2D and 3D materials
Exotic “second sound” phenomenon observed in pencil lead
Like a Trojan horse, graphene oxide can act as a carrier of organic pollutants to fish
Graphene nanoparticles and their influence on neurons
Graphene-coated face masks: COVID-19 miracle or another health risk?
Targeted coating improves graphene oxide membranes for nanofiltration
Graphene Engineering Innovation Centre announces new Tier-One partnership
High-performance graphene-based biosensors to help detect blood disorders
Manchester launches spin-out to bring innovative water-filtration technology to market
Acoustic graphene plasmons study paves way for optoelectronic applications
Stamp-sized graphene sheets riddled with holes could be boon for molecular separation
American Physical Society honors three MIT professors for physics research
Sparc launches graphene sensor project to detect human and animal diseases